跳至主要内容
临床试验/EUCTR2005-005012-25-FR
EUCTR2005-005012-25-FR进行中(未招募)1 期

Etude en simple aveugle évaluant l'efficacité et la tolérance du BF 2.649 dans le trouble de l'attention/hyperactivité de l'adulte

BIOPROJET0 个研究点目标入组 35 人开始时间: 2006年9月21日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
BIOPROJET
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Male and Female aged from 18 to 65 years old
  • - Ambulatory patients suffering from Attention Deficit/Hyperactivity Disorder (according to DSM-IV criteria)
  • - No specific medications for ADHD treatment
  • - Score superior to 46 on WURS scale
  • - Informed written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Psychiatric disorders: - All psychiatric diseases other than ADHD
  • Psychotropic medications:
  • - Any prescription of Atomoxetine, anti-depressants, anti-psychotics, mood stabilizers during the previous 4 weeks,
  • - Any psychostimulants (methylphenidate) and any medication with psychic effects in the past 2 weeks
  • - Severe systemic illnesses and any illness, which according to the investigator's judgement, will expose the patient to an excessive risk
  • - ECG: auriculo-ventricular block with PR>200 ms and/or QTc>450 ms
  • - Biological tests: values considered to be abnormal by the investigator

研究者

发起方
BIOPROJET

相似试验

尚未招募
不适用
A double blind pilot study testing the effectiveness of Biotene mouthwash versus Normal Saline mouthwash to reduce the symptoms associated with mucositis in high dose chemotherapy patients.Oral MucositisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCancer -
ACTRN12605000057684Auspharm Australia24
招募中
4 期
A double-blind study to evaluate the effectiveness of bioavailability enhancers to increase blood absorption of antioxidants and fat-soluble nutrients over a 48-hour period in otherwise healthy individuals.
ACTRN12619000953134RDC Global Pty Ltd610
已完成
不适用
Single blinded evaluation of the effectiveness of Neuro Psycho Physical Optimization protocol with Radio Electric Asymmetric Conveyer in stress-related disorders, assessed with Symptom Checklist-90 (SCL-90) and Psychological Stress Measure Test.
ACTRN12609000484246Istituto Rinaldi Fontani120
进行中(未招募)
不适用
Estudio abierto con evaluador ciego de la eficacia de las células mononucleares autólogas de médula ósea en la regeneración celular de un paciente con ictus isquémico agudo de la ACMTRATAMIENTO CON CÉLULAS MADRE DE MÉDULA OSEA EN PACIENTES CON ICTUS ISQUÉMICO AGUDO
EUCTR2007-003700-36-ESnidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias
进行中(未招募)
不适用
Estudio abierto con evaluador ciego de la eficacia de las células mononucleares autólogas de médula ósea en la regeneración muscular y vascular en pacientes con disfunción ventricular izquierda tras infarto de miocardio / Open estudy with blind regulator on the effectiveness of autologous bone marrow mononuclear cells in patients with left ventricular dysfunction after myocardia infarction.TRATAMIENTO DE ENFERMEDAD CORONARIA (IAM Y DISFUNCIÓN VENTRICULAR IZQUIERDA / TREATMENTOF CORONARY DISEASE (AMI AND LEFT VENTRICULAR DYSFUNTION)MedDRA version: 9.1Level: LLTClassification code 10011099Term: Coronary disease
EUCTR2006-005628-17-ESGRUPO DE TERAPIA CELULAR Y CARDIOVASCULAR DEL HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS
Etude en simple aveugle évaluant l'efficacité et la... | 临床试验